Recombinant DNA Advisory Committee - 12/1-2/94 
Jack Gluckman, University of Cincinnati 
Raymond Goldberg, Public 
Alan Goldhammer, Biotechnology Industry Organization 
J. Clay Goodman, Baylor College of Medicine 
Mario Gorziglia, Genetic Therapy, Inc. 
Richard Gregory, Canji, Inc. 
Robert Grossman, Baylor College of Medicine 
Paul Hallenbeck, Genetic Therapy, Inc. 
Susan Hamano, Cambridge Healthtech Institute 
Yutaka Hattori, National Cancer Center in Tokyo 
Evan Hersh, Arizona Cancer Center 
Douglas Hickman, T. Rowe Price Associates, Inc. 
Marc Horowitz, Texas Childrens Hospital 
Yukihito Ishizaka, Cleveland Clinic 
Jolynda Jones, Genetic Therapy, Inc. 
Nancy Kan, Pharmacia, Inc. 
Susumu Kanazawa, Kaken Pharmaceutical Company 
Kathy Kaufmann, GenVec 
Gary Kikuchi, Genetic Therapy, Inc. 
Rachel King, Genetic Therapy, Inc. 
Connie Kirby, Canji, Inc. 
Rebecca Kolberg, Journal of NCI Research 
Hitoshi Kotani, Genetic Therapy, Inc. 
Robert Kozak, Miles, Inc 
Karen Kozarsky, University of Pennsylvania 
Steve Kradjian, Vical, Inc 
Alan Lapey, Massachusetts General Hospital 
Ming-Fan Law, Canji, Inc 
Fred Ledley, Gene Medicine, Inc. 
Gloria Lee, Rhone-Poulenc Rorer 
Charles Link, Human Gene Therapy Research Institute 
Zhifeng Long, Genetic Therapy, Inc 
Russette Lyons, Genetic Therapy, Inc. 
Dan Maneval, Canji, Inc. 
Tony Marcel, TMC Development 
Stephen Marcus, Genetic Therapy, Inc 
Alan McClelland, Genetic Therapy, Inc 
C. Bruce McCullough, Schering-Plough Research Institute 
Gerard McGarrity, Genetic Therapy, Inc 
Amy McKee, FDC Reports 
Janice McTeague, Genzyme Corporation 
David Meeker, Genzyme Corporation 
Amy Melnick, American Society for Microbiology 
Setsu Mikumo, Japan Broadcasting Corporation 
John Miller, Cambridge Healthtech Institute 
Karen Millison, Genetic Therapy, Inc 
Masaaki Mizuno, Nagoya University 
Robert Moen, Geneic Sciences, Inc 
Donald Moorman, Human Gene Therapy Research Institute 
Richard Mosdcki, Genzyme Corporation 
Annemarie Moseley, Ingenex, Inc 
Aniceto Navarro, Smithsonian Institution 
Susan Nemeth, Schering-Plough Research Institute 
John Nemunaitis, Texas Oncology 
[432] 
Recombinant DNA Research, Volume 20 
